Fig. 3From: Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 miceBehavioural test A Scape latency of training in MWM and B Scape latency of probe trial. All data were measured in seconds. Statistical analysis was performed through two-way ANOVA. Significant differences were found in treatment variable: ## denote p < 0.01 C NORT, DI expressed in seconds. (n = 10 independent samples per group. Two-way ANOVA statistical analysis was performed (Treatment variable: #### denote p < 0.0001) (Diet variable: # denote p < 0.05)Back to article page